Profile
TIVC ABT BSX-PA BSX SYK MDT
Company Name Tivic Health Systems, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $3.68M $233.80B $175.45B $157.61B $150.40B $110.21B
Employees 0.01K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Jennifer Ernst Robert B. Ford Mr. Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
TIVC ABT BSX-PA BSX SYK MDT
Quant Rating Score 1 4 3 3 3
Quant Rating Strong Sell Buy Neutral Neutral Neutral
Trading
TIVC ABT BSX-PA BSX SYK MDT
Last Close $3.805 $134.38 $122.18 $106.53 $393.55 $86.02
High 52 $7.13 $140.22 $122.18 $106.66 $399.9 $94.5
Low 52 $0.2 $100.07 $122.18 $72.96 $315.94 $76.84
Price vs. 52 Week High -46.63 % -4.16 % 0 % -0.12 % -1.59 % -8.97 %
Price vs. 52 Week Low 1802.5 % 34.29 % 0 % 46.01 % 24.56 % 11.95 %
Total Return
TIVC ABT BSX-PA BSX SYK MDT
1 Month Return -7.87 % 0.6 % 0 % 1.21 % 2.89 % 3.66 %
3 Month Return 35.41 % 2.72 % 0 % 7.22 % 7.97 % -1.84 %
6 Month Return 1142.25 % 19.13 % 0 % 18.79 % 8.64 % 8.05 %
9 Month Return 1424.44 % 17.87 % 0 % 27.12 % 8.94 % -4.45 %
YTD Return 999.08 % 18.8 % 0 % 19.27 % 9.3 % 7.69 %
1 Year Return 875.64 % 29.32 % 0 % 38.33 % 15.66 % 9.29 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TIVC ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.7 % - - 0.83 % 3.27 %
Dividend Paid and Capex Coverage Ration (TTM) - 1.57 % 3.96 % 3.96 % 2.2 % 1.29 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.81 %
Payout Ratio (TTM) - 28.92 % 1.13 % 1.13 % 43.2 % 76.97 %
Growth
TIVC ABT BSX-PA BSX SYK MDT
Asset Growth -45.57 % 11.2 % 12.12 % -1.06 %
Gross Profit Growth -99.3 % 5.01 % 16.12 % 3.12 %
Revenue Growth -33.67 % 4.59 % 17.61 % 3.64 %
Revenue 3 Year -99.99 % -0.18 % 36.16 % 8.85 %
Revenue 5 Year -99.99 % 34.24 % 47.52 % 7.41 %
Revenue 10 Year -99.99 % 80.43 % 104.22 % 43.65 %
EBIT Growth 31.34 % 3.71 % 14.98 % -7.4 %
Net Income Growth 31.4 % 134.18 % 16.38 % -2.18 %
Net Income 3 Yeari Growth Per Share 99.99 % 94.27 % 72.14 % 3.26 %
Net Income 5 Yeari Growth Per Share 99.99 % 271.11 % -62.7 % -19.5 %
Net Income 10 Yeari Growth Per Share 99.99 % 410.99 % 524.92 % -9.48 %
Operating Income Growth 31.34 % 5.36 % 11.1 % -6.22 %
Operating Cash Flow Growth (CFG) 32.73 % 17.86 % 37.24 % 12.39 %
Operating 3 Year CFG 99.99 % -16.72 % 77.55 % 10.18 %
Operating 5 Year CFG 99.99 % 42.4 % 76.92 % -1.78 %
Operating 10 Year CFG 99.99 % 102.79 % 143.61 % 3.3 %
EPS Growth 88.87 % 134.55 % 16.67 % -2.12 %
EPS Diluted Growth 88.87 % 133.64 % 16.82 % -2.13 %
Book Value Per Share -99.99 % 23.54 % 11.25 % -2.26 %
Share Holder 3 Year Equity Growth Per Share -100 % 36.46 % 26.58 % -1.1 %
Share Holder 5 Year Equity Growth Per Share -99.99 % 56.53 % 48.35 % 1.66 %
Share Holder 10 Year Equity Growth Per Share -99.99 % 92.83 % 186.31 % 94.93 %
Dividend Per Share Growth - 8.02 % -100 % 1.54 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % 19.02 %
Dividend 5 Year Growth Per Share - 72.53 % - 38.05 %
Dividend 10 Year Growth Per Share - 148.92 % - 147.94 %
Debt Growth -100 % -5.37 % 17.44 % 6.91 %
Free Cash Flow Growth 33.65 % 25.54 % 55.31 % 13.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 26 Apr 2024
Profitability
TIVC ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM -22.29 % 55.89 % 67.15 % 67.15 % 63.57 % 64.06 %
Return on Assets TTM -150.28 % 16.58 % 5.06 % 5.06 % 6.21 % 5.09 %
Return on Equity TTM -180.23 % 30.76 % 9.56 % 9.56 % 10.73 % 9.62 %
Return on Capital Employed TTM -187.29 % 10.5 % 8.77 % 8.77 % 9.61 % 7.56 %
Net Income Per EBT TTM 100 % 183.58 % 81.97 % 81.97 % 85.78 % 82.85 %
EBT Per Ebit TTM 99.82 % 102.35 % 80.59 % 80.59 % 91.04 % 94.51 %
EBIT Per Revenue TTM -1101.94 % 16.97 % 17.52 % 17.52 % 15.77 % 17.76 %
Cash Flow To Debt Ratio TTM - 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Receivables Turnover TTM 39.69 4.38 6.52 6.52 5.86 5.15
Payables Turnover TTM 1.44 4.43 5.74 5.74 - 4.74
Inventory Turnover TTM 2.06 2.81 2.01 2.01 1.66 2.12
Fixed Asset Turnover TTM 437.29 % 387.34 % 517.94 % 517.94 % 656.62 % 490.52 %
Asset Turnover TTM 13.66 % 51.99 % 43.73 % 43.73 % 50.47 % 36.58 %
Operating Cash Flow Per Share TTM -8.3 5.12 2.58 2.58 11.23 5.49
Free Cash Flow Per Share TTM -8.3 3.81 1.94 1.94 9.37 4.04
Cash Per Share TTM 112.18 % 391.71 % 49.08 % 49.08 % 631.12 % 699.13 %
Operating Cash Flow Sales Ratio TTM -958.91 % 21.14 % 21.72 % 21.72 % 18.47 % 21 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 74.38 % 75.37 % 75.37 % 83.42 % 73.61 %
Cash Flow Coverage Ratios TTM - 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Price To Free Cash Flows Ratio TTM -0.74 35.12 53.62 54.86 42.05 21.26
Price To Operating Cash Flows Ratio TTM -0.46 26.23 40.35 41.28 35.03 15.66
Price Cash Flow Ratio TTM -0.46 26.23 40.35 41.28 35.03 15.66
Income Statement (TTM)
TIVC ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0B $23.24B $11.49B $11.49B $14.44B $21.97B
Gross Profit Ratio 0.26% 55.41% 68.61% 68.61% 63.91% 65.51%
EBITDA $-0.01B $10.83B $3.94B $3.94B $5.72B $5.96B
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -19.67 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
TIVC ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $8.84B $8.84B $12.19B $25.64B
Total Liabilities $0B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.84B $6.75B
Total Debt $0B $15.02B $11.15B $11.15B $13.6B $28.52B
Total Assets $0B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
TIVC ABT BSX-PA BSX SYK MDT
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.23B $0.05B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.01B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 136.15
ADGM Adagio Medical Holdings, Inc. 1.3
AEMD Aethlon Medical, Inc. 1.2
AFIB Acutus Medical, Inc. 0.002
AHCO AdaptHealth Corp. 9.43
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 189.35
ALUR Allurion Technologies Inc. 2.455
AMIX Autonomix Medical, Inc. Common Stock 1.565
ANIK Anika Therapeutics, Inc. 10.575
AORT Artivion, Inc. 31.12
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.23
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.105
AVNS Avanos Medical, Inc. 12.24
AVR Anteris Technologies Global Corp. Common Stock 3.806
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 10.87
ETFs With Exposure to TIVC
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 192.88
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 145.5
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 145.51
VEMPX Vanguard Extended Market Index InstlPlus 0 359.07
Unlock